{"timestamp": 1771609325.2500215, "value": {"ticker": "AUTL", "company_name": "Autolus Therapeutics plc", "short_name": "Autolus Therapeutics plc", "sector": "Healthcare", "industry": "Biotechnology", "country": "United Kingdom", "market_cap": 443128544, "float_shares": 84335484, "shares_outstanding": 266143286, "short_ratio": 6.3, "short_percent_of_float": 0.0764, "shares_short": 15435023, "shares_short_prior": 12295794, "insider_percent_held": 0.05562, "institution_percent_held": 0.78885, "total_cash": 367412992, "total_debt": 325180000, "total_revenue": 51128000, "revenue_growth": 0, "earnings_growth": 0, "profit_margins": 0.0, "gross_margins": -2.6478798, "operating_margins": -3.37931, "debt_to_equity": 122.5, "current_ratio": 6.194, "book_value": 0.997, "price_to_book": 1.67001, "operating_cashflow": -254179008, "free_cashflow": -267752128, "price": 1.665, "52w_high": 2.7, "52w_low": 1.105, "avg_volume": 2696903, "avg_volume_10d": 1165230, "full_time_employees": 647, "audit_risk": 0, "overall_risk": 0}}